Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.

about

Pharmacokinetics of 5-fluorouracil and increased hepatic dihydropyrimidine dehydrogenase activity levels in 1,2-dimethylhydrazine-induced colorectal cancer model rats.

P2860

Q46454725-82FC6F19-166F-4232-9FAA-8BE88A91A128

P2860

Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.

Item

http://www.wikidata.org/entity/Q48578124

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@en

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@nl

type

Item

label

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@en

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@nl

prefLabel

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@en

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@nl

P1476

Pharmacokinetics and distribut ...... n rats under oxidative stress.

@en

P2093

Kanji Takada

http://www.w3.org/2001/XMLSchema#string

Keizo Fukushima

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Sugioka

http://www.w3.org/2001/XMLSchema#string

Shinji Kobuchi

http://www.w3.org/2001/XMLSchema#string

Yukako Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells

Estimation of hydroxyl radical generation by salicylate hydroxylation method in kidney of mice exposed to ferric nitrilotriacetate and potassium bromate

Effects of acute exposure to aluminum on blood-brain barrier and the protection of zinc.

Pharmacologic treatment of depression during pregnancy.

Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.

Clinical pharmacokinetics of fluvoxamine.

Iron and CYP2E1-dependent oxidative stress and toxicity.

Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis.

The pharmacologic treatment of depression.

The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model.

P304

831-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10715762.2012.683430

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22486632

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.

about

P2860

P2860

Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698